{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-023954","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2023-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.761931+00:00","generated_at":"2026-06-11T09:00:38.746731+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BioLife execs to receive up to 100% of base salary in stock through Dec 2023","bullets":["CEO Michael Rice to receive 50% of base salary in vested shares for Aug 14-Dec 31, 2023; 50% in cash.","EVP Aby Mathew to receive 100% of base salary in shares; CFO and COO to receive 30% in shares.","All board members will receive all remaining 2023 cash compensation in fully vested shares.","Compensation reverts to full cash payment on January 1, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-023954","json":"https://secwatch.observer/filing/0001437749-23-023954.json","markdown":"https://secwatch.observer/filing/0001437749-23-023954.md","text":"https://secwatch.observer/filing/0001437749-23-023954.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000143774923023954/0001437749-23-023954-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000143774923023954/bioli20230816_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T09:00:38.746731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}